Abstract:Objectives Dilated cardiomyopathy (DCM) is a major cause of sudden cardiac death with lethal ventricular arrhythmias. So far, the genetic mutations of DCM are mainly related to the sarcomeric protein, and mutations in SCN5A which encoding μ-subunit of sodium channel also have been involved. However, KCNQ1 gene encoding in potassium channel has not been found in DCM patients. The purpose of this study was to demonstrate if DCM with ventricular tachycardia and prolonged QT interval is caused by mutation in the KCNQ1 gene. Methods Clinical features and DNA samples of DCM patients with lethal ventricular arrhythmia were collected. The candidate genes including SCN5A, KCNQ1, KCNE1 and KCNE2 were screened by the direct sequencing to look for the mutations. Whole cell patch clamp analysis of HEK293 cells expressing Wild-type and mutation KCNQ1 channel was used to investigate the channels biophysical properties. The current-voltage relationships, peak current, current density, the voltage dependence of steady-state activation and inactivation of mutated channel were investigated. Results Twelve unrelated DCM patients with lethal ventricular arrhythmia were included and clinical features were available in medical records. Three patients (25%) presented cardiac conduction system abnormality, and nine patients (75%) showed QT prolongation in ECG recordings before amiodarone therapy. A G to A missense mutation in KCNQ1 gene was identified in a 60-year-old man with concomitant DCM and incessant VT and prolonged QT interval, which is at nucleotide site 1190 that resulted in a amino-acid substitution of arginine to glutamine at amino-acid site 397 (R397Q) in the C-terminal region of KCNQ1 gene. Whole cell patch clamp analysis of HEK293 cells expressing WT and mutant KCNQ1 was used to investigate the biophysical properties of the channel. It showed that R397Q (n = 19) decreased I ks current density dramatically compared with WT (14.34 ± 1.73 vs 23.25 ± 2.31, P 0.5 and slope factor for the voltage dependence of activation comparing to WT. Meanwhile, this patient experienced recurrent VT only 20 months post radio frequency ablation (RFCA). Finally an implantable cardioverter defibrillator (ICD) was successfully implanted and he had been without complaints up to the 3 years of follow-up visit. Conclusions It was firstly reported that a loss of function in KCNQ1 gene may cause the overlapping phenotype of DCM, ventricular tachycardia and prolonged QT interval. The reduction of I ks in R397Q did not significantly change the properties of gate. It seems that RFCA is the assistant to improve the incessant ventricular arrhythmia in the patients with abnormal structure heart disease and genetic background, ICD is necessary.

Association Between SCN5A R225Q Variant and Dilated Cardiomyopathy: Potential Role of Intracellular Ph and WNT/β-catenin Pathway

Novel Idiopathic DCM-related SCN5A Variants Localised in DI-S4 Predispose Electrical Disorders by Reducing Peak Sodium Current Density.

Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart.

Molecular and Clinical Characterization of a Novel SCN5A Mutation Associated with Atrioventricular Block and Dilated Cardiomyopathy.

Prevalence and Spectrum of LRRC10 Mutations Associated with Idiopathic Dilated Cardiomyopathy.

A Novel Nkx2-5 Loss-Of-Function Mutation Predisposes to Familial Dilated Cardiomyopathy and Arrhythmias

GW24-e0353 A novel mutation R397Q in KCNQ1 gene caused dilated cardiomyopathy with ventricular tachycardia and prolonged QT interval

Genetic Mutation of Familial Dilated Cardiomyopathy Based on Next‑generation Semiconductor Sequencing.

Identification of a Novel Variant in N-cadherin Associated with Dilated Cardiomyopathy.

The Trans KCNMA1-M744T and Cis ANXA11-I457V and DYDC2-P123R Variants Are Associated with Familial Dilated Cardiomyopathy

Abstract 050: Mutational Spectrum in a Cohort of Chinese Sporadic Dilated Cardiomyopathy by Next-generation Sequencing

Altered Cardiac Sodium Channel Function Resulting from Voltage-Sensor Mutation is a Risk Factor for Dilated Cardiomyopathy

ZBTB17 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

A Novel GATA4 Loss-of-function Mutation Responsible for Familial Dilated Cardiomyopathy

Prevalence And Spectrum Of Nkx2-5 Mutations Associated With Sporadic Adult-Onset Dilated Cardiomyopathy

Correlational Study of CD226 Gene Single Nucleotide Polymorphism and Dilated Cardiomyopathy in the Chinese Han Population

Detection and functional characterization of a novel <i>MEF2A</i> variation responsible for familial dilated cardiomyopathy

GATA5 Loss-of-function Mutation in Familial Dilated Cardiomyopathy.

Relationship Between Δ-Sarcoglycan Gene and Dilated Cardiomyopathy

MEF2C loss-of-function mutation associated with familial dilated cardiomyopathy.

Frameshift variants in C10orf71 cause dilated cardiomyopathy in human, mouse, and organoid models